Related Experiment Video

Updated: May 31, 2026

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice
09:29

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Published on: June 11, 2020

Pyridoxal phosphate-dependent neonatal epileptic encephalopathy

S Bagci1, J Zschocke, G F Hoffmann

  • 1Centre for Paediatrics, Department of Neonatology, University of Bonn, Germany.

BMJ Case Reports
|June 21, 2011
PubMed

Insights

Pyridoxal phosphate (PLP) is crucial for neurotransmitter synthesis. A genetic mutation affecting PLP production caused neonatal seizures unresponsive to standard treatments, highlighting the need for PLP consideration.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Pyridoxal phosphate (PLP) is an essential cofactor derived from vitamin B6.
  • PLP is vital for numerous metabolic pathways, including neurotransmitter synthesis.
  • Deficiencies in PLP metabolism can lead to neurological dysfunction.

Purpose of the Study:

  • To describe a novel genetic mutation affecting pyridox(am)ine-5'-phosphate oxidase.
  • To investigate the clinical presentation of neonatal seizures caused by this mutation.
  • To establish the therapeutic efficacy of pyridoxal phosphate in such cases.

Main Methods:

  • Genetic analysis of a family with affected neonates.
  • Clinical assessment of seizure characteristics and treatment response.
  • Biochemical evaluation of vitamin B6 metabolism.

Main Results:

  • A mutation in the pyridox(am)ine-5'-phosphate oxidase gene was identified.
  • Affected neonates presented with severe seizures refractory to pyridoxine and conventional anticonvulsants.
  • Seizures were effectively managed with pyridoxal phosphate administration.

Conclusions:

  • Pyridoxal phosphate oxidase deficiency is a treatable cause of neonatal epileptic encephalopathy.
  • Early diagnosis and treatment with pyridoxal phosphate are critical for managing these seizures.
  • This finding expands the understanding of vitamin B6-dependent epilepsy.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.